리보노락톤리보노락톤

Ribonolactone

HCID 111064

기본 정보

CAS: 3327-63-7
표준 SMILES: O=C1O[C@H](CO)[C@@H](O)[C@H]1O
InChIKey: CUOKHACJLGPRHD-BXXZVTAOSA-N
분자식: C5H8O5
평균 분자량: 148.11 g/mol

개요

D-ribono-1,4-lactone is a five-membered form of ribonolactone having D-configuration. It has a role as a metabolite. It is a butan-4-olide and a ribonolactone. It is functionally related to a D-ribonic acid.

이름 및 식별자

우선 이름: Ribonolactone
IUPAC: (3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-one
현지명: 리보노락톤리보노락톤
영어명: ribonolactone
분자식: C5H8O5
분자량: 148.11

이름 및 동의어

Ribonolactone(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-oneD-Ribono-gamma-lactone64E63NC231Ribonic acid, gamma-lactone, D-NSC-1031RefChem:883599CHEBI:37434226-256-5D-Ribono-1,4-lactone5336-08-3D-Ribonolactone

이름 더 보기

리보노락톤리보노락톤Ribono-1,4-lactoneRibonic acid, γ-lactoneL-Ribono-1,4-lactone-3327-63-7

D(+)-Ribonic acid gamma-lactone3327-63-7Ribono-gamma-lactoneD-(+)-Ribono-1,4-lactoneD-Ribopentono-1,4-lactoneD-(+)-Ribonic acid gamma-lactone(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-oneMFCD00063241

데이터베이스 식별자

CAS: 3327-63-7、5336-08-3
PubChem CID: 111064
DTXSID: DTXSID201347750
ChEMBL: CHEMBL607627
ChEBI: CHEBI:74168
UNII: 64E63NC231
EC Number: 226-256-5
Nikkaji: J217.896F

물성

구조 계산 물성

XLogP: -1.4
극성 표면적: 87 Å²
수소 결합 공여자 수: 3
수소 결합 수용자 수: 5
회전 가능 결합 수: 1
무거운 원자 수: 10
형식 전하: 0
복잡도: 145

실험 및 물리화학적 성질

Cosmetics · 2건

Cosmetic ingredients (Ribonolactone) -> CIR (Cosmetic Ingredient Review)

Humectant

Melting Point83 - 85 °C

Physical DescriptionSolid

물리화학적 성질

끓는 점: 364.3 · 364.3±11.0 °C(Predicted)
밀도: 1.667 · 1.667
산도 계수 (pKa): 12.1 · 12.10±0.60(Predicted)

안전 및 규제

유해성 정보

Regulatory Information · 2건

Chemical: D-Ribonic acid, .gamma.-lactone

D-Ribonic acid, .gamma.-lactone: Does not have an individual approval but may be used under an appropriate group standard

독성 정보

Toxicity Summary · 2건

Additionally, the Panel concluded the available data are insufficient to make a determination that Ribonolactone is safe under the intended conditions of use in cosmetic formulations.

The available data are insufficient to support safety